Reaffirms the commitment made at the 2010 MDG Summit and calls on development partners to work with LDCs to improve access to medicines, encourage the development of technology and the transfer of technology under mutually agreed terms and conditions, the production of affordable, safe, effective and good quality medicines, fostering the production of innovative medicines, generics, vaccines and other health commodities.
No new or numerical targets were set. See 2010 MDG Summit commitment.
Lack of numerical targets prevents proper monitoring of progress.
No numerical targets were set, thus it is difficult to measure a gap.
Not new commitments.